Assessment of Serum Levels of Adenosine Deaminase and Immunoglobulin E in Patients With Chronic Spontaneous Urticaria

Sohag University0 sites90 target enrollmentAugust 15, 2023

ConditionsChronic Spontaneous Urticaria

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Chronic Spontaneous Urticaria
Sponsor: Sohag University
Enrollment: 90
Primary Endpoint: Serum level of IgE
Status: Not yet recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

adenosine deaminase activity (ADA) has been reported to be elevated in various diseases such as psoriasis, acne and juvenile idiopathic arthritis. There is no previous studies that assessed ADA in chronic spontaneous urticaria (CSU) .

Registry

clinicaltrials.gov

Start Date

August 15, 2023

End Date

March 31, 2024

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Sohag University

Responsible Party

Principal Investigator

Ahmed Mohamed Ahmed

Resident physician at Dermatology department, Sohag University

Sohag University

Eligibility Criteria

Inclusion Criteria

•adult patients complaining of CSU and a group of age and sex-matched healthy controls (blood donors).

Exclusion Criteria

•Pregnancy and lactation.
•Patients with systemic diseases, especially those with autoimmune diseases and infections.
•Patients with skin diseases.
•Patients on medications such as antibiotics, nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, anticonvulsants, penicillin, and combined oral contraceptives.